Event Details
- Event Type: Post-results conference call
- Purpose: To discuss financial performance for quarter and half year ended September 30, 2026 (Q2 and H1 FY2027)
- Date: Thursday, November 12, 2026
- Time: 4:30 PM IST
Management Participants
The following management team members will represent the company:
- Mr. C.C. Paarthipan, Chairman
- Mr. Vivek Partheeban, Vice Chairman
- Mr. Ashok Partheeban, Vice Chairman
- Dr. Sridhar Ganesan, Managing Director
- Mr. D. Muralidharan, Whole Time Director and CFO
Company Description
Caplin Point Laboratories Limited is described as "a rapidly expanding and fully integrated pharmaceutical company" in the disclosure.
Contingency Note
The schedule of the meeting is subject to change due to exigencies on the part of Analyst or Company.
Financial Impact
Financial impact not quantified in the disclosure. This is an announcement of an upcoming event to discuss already announced financial results.